Dynavax Technologies Corp.https://pcaobus.org/form-ap-filings/36033/36033Dynavax Technologies Corp.360333/21/2019 9:29:16 AM2018613afe77-320f-41c1-b06b-3f73ea392f3042Ernst & Young LLP80914Dynavax Technologies Corp.1029142DVAX0004201800Darcyann Kehaulani Lopes Beauchemin00042018001251Ernst & Young GmbH WirtschaftspruefungsgesellschaftTrue
Five Prime Therapeutics, Inc.https://pcaobus.org/form-ap-filings/34816/34816Five Prime Therapeutics, Inc.348163/13/2019 9:44:18 AM201806854473-2b61-4a6a-bbb7-3f86a231825d42Ernst & Young LLP170710Five Prime Therapeutics, Inc.1175505FPRX0004201800Darcyann Kehaulani Lopes Beauchemin0004201800True
Natera, Inc.https://pcaobus.org/form-ap-filings/20630/20630Natera, Inc.206303/27/2018 1:59:34 PM2017565f62e6-956b-4e84-b5f3-7911a7881bf242Ernst & Young LLP585165Natera, Inc.1604821NTRA0004201800Darcyann Kehaulani Lopes Beauchemin0004201800True
Five Prime Therapeutics, Inc.https://pcaobus.org/form-ap-filings/19140/19140Five Prime Therapeutics, Inc.191403/16/2018 8:19:38 PM2017a78f3b52-b32e-4e10-ab80-5df16fa9b77c42Ernst & Young LLP170710Five Prime Therapeutics, Inc.1175505FPRX0004201800Darcyann Kehaulani Lopes Beauchemin0004201800True